Skip to main content
. 2020 Nov 25;27(8):1277–1284. doi: 10.1093/ibd/izaa301

TABLE 2.

Cox Proportional Hazards Model for Treatment Failure in Patients With CD Treated to Target of Clinical and Endoscopic Remission

Variables Univariate Multivariate
HR 95% CI P HR 95% CI P
Age (y) 0.995 0.980-1.012 0.580
Female 0.914 0.563-1.483 0.716
Current smoker 0.882 0.354-2.195 0.787
Early CD* 0.798 0.473-1.347 0.398
Age at diagnosis (y)
 A1 (≤16) 1
 A2 (17-40) 1.350 0.698-2.612 0.373
 A3 (>40) 1.295 0.561-2.992 0.545
Location of disease
 L1 (ileum) 1 1
 L2 (colon) 0.545 0.274-1.087 0.085 0.700 0.317-1.546 0.378
 L3 (ileocolon) 0.802 0.439-1.467 0.474 0.901 0.474-1.713 0.750
Behavior of disease
 B1 (nonstricturing and nonpenetrating) 1 1
 B2 or B3 1.640 1.001-2.687 0.049 1.344 0.706-2.558 0.369
History of perianal disease 1.150 0.670-1.976 0.612
History of abdominal surgery 1.702 1.021-2.836 0.041 1.116 0.585-2.130 0.739
Prior exposure to anti-TNF agent (before current therapy) 1.769 1.087-2.878 0.022 1.703 1.033-2.806 0.037
Time taken to achieve ER (mo) 0.985 0.962-1.009 0.224
Histologic remission 0.584 0.362-0.943 0.028 0.574 0.352-0.936 0.026

*Definition of early CD: disease duration <2 years.

ER indicates endoscopic remission; HR, hazard ratio.